EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.21.B39 | Adenocarcinoma |
34510543 |
Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
2
1
0 |
| 3.4.21.B39 | Adenocarcinoma of Lung |
30755669 |
PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
1
2
1 |
| 3.4.21.B39 | Breast Neoplasms |
10608802 |
The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. |
unassigned |
0 |
| 3.4.21.B39 | Breast Neoplasms |
18804527 |
Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model. |
causal interaction
unassigned |
1
0 |
| 3.4.21.B39 | Breast Neoplasms |
21868565 |
Evaluation of Kallikrein-related Peptidase 5 Expression and its Significance for Breast Cancer Patients: Association with Kallikrein-related Peptidase 7 Expression. |
diagnostic usage
unassigned |
3
0 |
| 3.4.21.B39 | Breast Neoplasms |
21906360 |
Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions. |
causal interaction
diagnostic usage
ongoing research
unassigned |
2
4
2
0 |
| 3.4.21.B39 | Breast Neoplasms |
25593998 |
Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
1
1
0 |
| 3.4.21.B39 | Carcinogenesis |
34503205 |
Kallikrein 5 Inhibition by the Lympho-Epithelial Kazal-Type Related Inhibitor Hinders Matriptase-Dependent Carcinogenesis. |
therapeutic application
unassigned |
2
0 |
| 3.4.21.B39 | Carcinoma |
19820362 |
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
2
0 |
| 3.4.21.B39 | Carcinoma |
21163944 |
Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma. |
unassigned |
0 |
